Dealing with the intricacies of regulatory and compliance issues on a global basis can be a complicated affair. Robert Pietrusko of ViroPharma tells NGP about their impact.
With a vision to become the Toyota of the pharmaceutical industry, Steve Dreamer helped to introduce a new concept in Novartis Pharma AG’s department Technical Operations – one that eliminated hierarchical work structures and the conventional supply
Genentech’s Robert Garnick was a very early pioneer in the biotechnology industry with direct experience in developing the very first biotech drugs. Here he talks about the company’s work in age-related macular degeneration.
Properly planned, executed and managed stability studies are critical for understanding data generated during clinical trials.